Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Ascorbic Acid Market by Type (Sodium ascorbate, Potassium Ascorbate, Calcium Ascorbate, Magnesium Ascorbate, Others), by Application (Food and beverages, Pharmaceutical, Beauty and personal care, Animal feed), by Form (Powder, Liquid): Global Opportunity Analysis and Industry Forecast, 2021-2031

A07444

Pages: 370

Charts: 70

Tables: 307

Ascorbic Acid Market Research, 2031

The global ascorbic acid market was valued at $1.3 billion in 2021, and is projected to reach $2.2 billion by 2031, growing at a CAGR of 5.2% from 2022 to 2031.

 

Ascorbic acid (C6H8O6) is naturally formed from citrus fruits such as lemons, grapefruit, limes, and others. It is synthesized artificially by the fungus Aspergillus Niger and Candida lipolytica, which generates more ascorbic acid than the others. Ascorbic acid comes in several variants: sodium ascorbate, potassium ascorbate, calcium ascorbate, magnesium ascorbate, and others. Sodium ascorbate is the most common type used to provide a sour and nutritional flavor to food & beverages, and also serves as a preservative, pH indicator, antioxidant, and coloring agent.

Ascorbic acid production and processing were hampered, owing to the effect of COVID-19 that has caused  disruption in the distribution channel & difficulties in obtaining production inputs such as raw material, machinery, and the stringent restrictions on trades and imports from the government. Other challenges were seasonal such as border-crossing restrictions and limited access to professional services and labor. As a result of these concerns, there was a drop in Ascorbic Acid Market Demand and decrease in processing capacity for production, which led to worse sales conditions, thus delaying overall production and market activities. Calcium additives, such as calcium ascorbate, are mostly found in bakery and dairy products because as they work as an functional agent to provide energy and antioxidants. The negative effects of sodium ascorbate have provided an opportunity for the increased usage of ascorbic acid in food and beverages products. Ascorbic acid is the appropriate substitute for sodium phosphate additives as it can act as a preservative and emulsifying agent. Rise in use of functional food acid propels the ascorbic acid market growth.

Increase in demand for functional food & beverages is a key driver for the ascorbic acid market across the globe. Moreover, innovative technologies, the introduction of production techniques, and a heavy inflow of investments in R&D activities are the other factors that are expected to contribute to growth of the ascorbic acid market. There is an upcoming trend of using natural flavor essence such as ascorbic acid, owing to a rise in health awareness. Furthermore, rise in demand for stabilizers and antioxidant food ingredients across European countries to produce commercialized clean label or green food products that are free of additives and other harmful chemicals, propel the growth of the natural ascorbic acid regulators. Technological strides make it possible for manufacturers to develop innovative flavors to cater to the change in customer taste requirements. Applications of advanced technologies provide innovative and novel tastes in food. Innovation in ascorbic acid production and the growth in their demand across emerging economies are expected to open new opportunities for the Ascorbic Acid Market players in during the forecast period.

Emerging markets such as Asia-Pacific, Latin America, and Africa are witnessing a rise in population, economic growth, urbanization, and increase in knowledge of the benefit of consuming food, rich in ascorbic acid. More than 75% of the  population of the world is projected to dwell in Asia and Africa. Majority of the countries in these two regions are emerging nations and are experiencing strong economic growth. Rise in penetration of quick-service restaurants and fast-food chains, beverage processing companies, and food processing companies boosts the demand for ascorbic acid owing to its functional properties useful in food processing as an ingredient. . Moreover, a significant rise in the consumption of soft drinks and sodas fuels growth of ascorbic acid due to the offerings of flavor and taste. Presence of a large population and their consumption behavior  propel demand for meat products, soft drinks, and processed foods across the developing regions. This is expected to increase the demand for ascorbic acid among the food & beverages manufacturers in the developing regions.

Ascorbic acids are vital ingredients used in food & beverages products. They are expected to witness significant growth in the future, owing to their wide range of application as a preservative, flavoring agent, taste enhancer, or taste modifier in confectionery, sauces, bakery, and others. Moreover, growth in demand for cold drink and other food & beverages contributes to the Ascorbic Acid Market expansion. The impact of these drivers is expected to increase significantly, owing due to a rise in awareness about the benefits of ascorbic acid. However, overconsumption of these regulators leads to health issues such as diarrhea, nausea, and vomiting, thus hindering the market growth. The cost of ascorbic acid regulators is expected to reduce in the near future, with the advancements in technology.

During the period of COVID-19, the government of the different countries has been dividing different industries into categories of essentials and non-essentials. Operations of a few food additive companies were declared "essentials" by the U.S. government, permitting operations at their facilities and continuing sales in accordance with those requirements. In Mexico, business operations were classified as "non-essential" for a period during the pandemic. The sales of end users such as food sector and cosmetics were impacted since the consumers were unable to purchase food and other items during the government-mandated shutdown, negatively impacting customer demand for the products.

Furthermore, government-enacted stay-at-home directives have considerably curtailed the ability of food & beverages manufacturing companies to acquire particular food additives such as ascorbic acid in the U.S. and other international markets. COVID-19 has had a negative influence on the larger economy of the affected nations, hurting economic development, the efficient operation of financial markets, foreign currency values, and interest rates. Changes in customer tastes and perceptions diminished demand for the items, lowering sales and profitability thus harming their business. Insolvency of customers, leading to additional provisions for credit losses, lower demand, including transaction delays or cancellations, and counterparty failures all had a negative impact on their business.

Key players profiled in this report include Koninklijke DSM N.V., Northeast Pharmaceutical Group Co., CSPC Pharmaceutical Group Limited, Muby Chemicals, Shandong Luwei Pharmaceutical, Glanbia Nutritionals China (Suzhou) Co., Ltd., LabChem Inc., Merck KGaA, Foodchem International Corporation, Blagden Speciality Chemicals Ltd., Bactolac Pharmaceutical Inc., Aland Nutraceuticals Group, Fujifilm, Medisca Inc., Superior Supplement Manufacturing, Pharmavit, Reckon Organics Pvt. Ltd., ChemCeed LLC, Botanic Healthcare, and  Vega Group company limited.

The ascorbic acid market is segmented into type, form, application, and region. On the basis of type, the Ascorbic Acid Market is divided into sodium ascorbate, potassium ascorbate, calcium ascorbate magnesium ascorbate, and others. On the basis of form, the market is bifurcated into powder and liquid. On the basis of application, it is divided into food and beverages, pharmaceuticals, beauty & personal care, and animal feed. On the basis of region, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (France, Germany, Italy, Spain, UK, and the Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia, and Rest of Asia-Pacific), and LAMEA (Latin America, Middle East, and Africa). According to ascorbic acid market analysis, on the basis of form, the powder segment has gained a major Ascorbic Acid Market Share in the global market in 2021 and is expected to sustain its hold during the forecast period.

[APPLICATIONGRAPH]

On the basis of application, the food & beverages segment has dominated the ascorbic acid market. The beverages market is one of the top growing markets globally, with the increase in population, rise in popularity of flavored carbonated drinks, and rise in product launches by the beverage manufacturers.

[TYPEGRAPH]

On the basis of type, the ascorbic acid market is categorized into sodium ascorbate, potassium ascorbate, calcium ascorbate, magnesium ascorbate, and others. The sodium ascorbate segment was the highest revenue contributor and is expected to remain dominant during the Ascorbic Acid Market Forecast period.

[FORMGRAPH]

On the basis of form, the Ascorbic Acid Market Size is classified into powder and liquid. The powder segment accounted for the highest revenue in the year 2021. However, the liquid segment is anticipated to grow at a significant rate during the forecast period.

[REGIONGRAPH]

On the basis of region, Asia-Pacific dominated the ascorbic acid market in 2021 and is expected to remain dominant during the forecast period. Asia-Pacific consumers acknowledge the consumption of packaged food as they help to save time & replenish hunger. China is the largest ascorbic acid manufacturing country in the world and has the highest share of export for ascorbic acid.  The Ascorbic Acid Market is expected to grow with evolving regulatory dynamics in the China and an increase in demand for natural variants.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current Ascorbic Acid Market Trends, estimations, and dynamics of the ascorbic acid market analysis from 2021 to 2031 to identify the prevailing ascorbic acid market opportunity.
  • The Ascorbic Acid Market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the ascorbic acid market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global Ascorbic Acid Market Size.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the Ascorbic Acid Industry players.
  • The report includes the analysis of the regional as well as global Ascorbic Acid Industry trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

  • By Application
    • Food and beverages
    • Pharmaceutical
    • Beauty and personal care
    • Animal feed
  • By Type
    • Potassium Ascorbate
      • Sub-type
        • Flavored
        • Unflavored
    • Calcium Ascorbate
      • Sub-type
        • Flavored
        • Unflavored
    • Magnesium Ascorbate
      • Sub-type
        • Flavored
        • Unflavored
    • Others
      • Sub-type
        • Flavored
        • Unflavored
    • Sodium ascorbate
      • Sub-type
        • Flavored
        • Unflavored
  • By Form
    • Powder
    • Liquid
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Latin America
      • Middle East
      • Africa


Key Market Players

  • FUJIFILM Corporation
  • Glanbia PLC
  • Superior Supplement Manufacturing
  • Botanic Healthcare
  • Merck KGaA
  • Chemceed
  • ACP Chemicals Inc
  • Foodchem International Corporation
  • Reckon Organics Private Ltd.
  • Bactolac Pharmaceutical Inc.
  • Blagden Specialty Chemicals Ltd.
  • Medisca Inc.
  • Luwei Pharmaceutical Group Co., Ltd
  • Northeast Pharmaceutical Group Co., Ltd.
  • Aland Health Holding Ltd
  • Pharmavit
  • CSPC Pharmaceutical Group Limited
  • Koninklijke DSM N.V.
  • Muby Chemicals
  •  Vega Group company limited
  • CHAPTER 1:INTRODUCTION

    • 1.1.Report description

    • 1.2.Key market segments

    • 1.3.Key benefits to the stakeholders

    • 1.4.Research Methodology

      • 1.4.1.Secondary research

      • 1.4.2.Primary research

      • 1.4.3.Analyst tools and models

  • CHAPTER 2:EXECUTIVE SUMMARY

    • 2.1.Key findings of the study

    • 2.2.CXO Perspective

  • CHAPTER 3:MARKET OVERVIEW

    • 3.1.Market definition and scope

    • 3.2.Key findings

      • 3.2.1.Top investment pockets

    • 3.3.Porter’s five forces analysis

    • 3.4.Market dynamics

      • 3.4.1.Drivers

      • 3.4.2.Restraints

      • 3.4.3.Opportunities

    • 3.5.COVID-19 Impact Analysis on the market

    • 3.6.Regulatory Guidelines

  • CHAPTER 4: ASCORBIC ACID MARKET, BY TYPE

    • 4.1 Overview

      • 4.1.1 Market size and forecast

    • 4.2 Sodium ascorbate

      • 4.2.1 Key market trends, growth factors and opportunities

      • 4.2.2 Market size and forecast, by region

      • 4.2.3 Market share analysis by country

      • 4.2.4 Sodium ascorbate Ascorbic Acid Market by Sub-type

        • 4.2.4.1 Flavored Market size and forecast, by region
        • 4.2.4.2 Unflavored Market size and forecast, by region
    • 4.3 Potassium Ascorbate

      • 4.3.1 Key market trends, growth factors and opportunities

      • 4.3.2 Market size and forecast, by region

      • 4.3.3 Market share analysis by country

      • 4.3.4 Potassium Ascorbate Ascorbic Acid Market by Sub-type

        • 4.3.4.1 Flavored Market size and forecast, by region
        • 4.3.4.2 Unflavored Market size and forecast, by region
    • 4.4 Calcium Ascorbate

      • 4.4.1 Key market trends, growth factors and opportunities

      • 4.4.2 Market size and forecast, by region

      • 4.4.3 Market share analysis by country

      • 4.4.4 Calcium Ascorbate Ascorbic Acid Market by Sub-type

        • 4.4.4.1 Flavored Market size and forecast, by region
        • 4.4.4.2 Unflavored Market size and forecast, by region
    • 4.5 Magnesium Ascorbate

      • 4.5.1 Key market trends, growth factors and opportunities

      • 4.5.2 Market size and forecast, by region

      • 4.5.3 Market share analysis by country

      • 4.5.4 Magnesium Ascorbate Ascorbic Acid Market by Sub-type

        • 4.5.4.1 Flavored Market size and forecast, by region
        • 4.5.4.2 Unflavored Market size and forecast, by region
    • 4.6 Others

      • 4.6.1 Key market trends, growth factors and opportunities

      • 4.6.2 Market size and forecast, by region

      • 4.6.3 Market share analysis by country

      • 4.6.4 Others Ascorbic Acid Market by Sub-type

        • 4.6.4.1 Flavored Market size and forecast, by region
        • 4.6.4.2 Unflavored Market size and forecast, by region
  • CHAPTER 5: ASCORBIC ACID MARKET, BY APPLICATION

    • 5.1 Overview

      • 5.1.1 Market size and forecast

    • 5.2 Food and beverages

      • 5.2.1 Key market trends, growth factors and opportunities

      • 5.2.2 Market size and forecast, by region

      • 5.2.3 Market share analysis by country

    • 5.3 Pharmaceutical

      • 5.3.1 Key market trends, growth factors and opportunities

      • 5.3.2 Market size and forecast, by region

      • 5.3.3 Market share analysis by country

    • 5.4 Beauty and personal care

      • 5.4.1 Key market trends, growth factors and opportunities

      • 5.4.2 Market size and forecast, by region

      • 5.4.3 Market share analysis by country

    • 5.5 Animal feed

      • 5.5.1 Key market trends, growth factors and opportunities

      • 5.5.2 Market size and forecast, by region

      • 5.5.3 Market share analysis by country

  • CHAPTER 6: ASCORBIC ACID MARKET, BY FORM

    • 6.1 Overview

      • 6.1.1 Market size and forecast

    • 6.2 Powder

      • 6.2.1 Key market trends, growth factors and opportunities

      • 6.2.2 Market size and forecast, by region

      • 6.2.3 Market share analysis by country

    • 6.3 Liquid

      • 6.3.1 Key market trends, growth factors and opportunities

      • 6.3.2 Market size and forecast, by region

      • 6.3.3 Market share analysis by country

  • CHAPTER 7: ASCORBIC ACID MARKET, BY REGION

    • 7.1 Overview

      • 7.1.1 Market size and forecast

    • 7.2 North America

      • 7.2.1 Key trends and opportunities

      • 7.2.2 North America Market size and forecast, by Type

        • 7.2.2.1 North America Sodium ascorbate Ascorbic Acid Market by Sub-type
        • 7.2.2.2 North America Potassium Ascorbate Ascorbic Acid Market by Sub-type
        • 7.2.2.3 North America Calcium Ascorbate Ascorbic Acid Market by Sub-type
        • 7.2.2.4 North America Magnesium Ascorbate Ascorbic Acid Market by Sub-type
        • 7.2.2.5 North America Others Ascorbic Acid Market by Sub-type
      • 7.2.3 North America Market size and forecast, by Application

      • 7.2.4 North America Market size and forecast, by Form

      • 7.2.5 North America Market size and forecast, by country

        • 7.2.5.1 U.S.
          • 7.2.5.1.1 Key market trends, growth factors and opportunities
          • 7.2.5.1.2 Market size and forecast, by Type
          • 7.2.5.1.3 Market size and forecast, by Application
          • 7.2.5.1.4 Market size and forecast, by Form
        • 7.2.5.2 Canada
          • 7.2.5.2.1 Key market trends, growth factors and opportunities
          • 7.2.5.2.2 Market size and forecast, by Type
          • 7.2.5.2.3 Market size and forecast, by Application
          • 7.2.5.2.4 Market size and forecast, by Form
        • 7.2.5.3 Mexico
          • 7.2.5.3.1 Key market trends, growth factors and opportunities
          • 7.2.5.3.2 Market size and forecast, by Type
          • 7.2.5.3.3 Market size and forecast, by Application
          • 7.2.5.3.4 Market size and forecast, by Form
    • 7.3 Europe

      • 7.3.1 Key trends and opportunities

      • 7.3.2 Europe Market size and forecast, by Type

        • 7.3.2.1 Europe Sodium ascorbate Ascorbic Acid Market by Sub-type
        • 7.3.2.2 Europe Potassium Ascorbate Ascorbic Acid Market by Sub-type
        • 7.3.2.3 Europe Calcium Ascorbate Ascorbic Acid Market by Sub-type
        • 7.3.2.4 Europe Magnesium Ascorbate Ascorbic Acid Market by Sub-type
        • 7.3.2.5 Europe Others Ascorbic Acid Market by Sub-type
      • 7.3.3 Europe Market size and forecast, by Application

      • 7.3.4 Europe Market size and forecast, by Form

      • 7.3.5 Europe Market size and forecast, by country

        • 7.3.5.1 France
          • 7.3.5.1.1 Key market trends, growth factors and opportunities
          • 7.3.5.1.2 Market size and forecast, by Type
          • 7.3.5.1.3 Market size and forecast, by Application
          • 7.3.5.1.4 Market size and forecast, by Form
        • 7.3.5.2 Germany
          • 7.3.5.2.1 Key market trends, growth factors and opportunities
          • 7.3.5.2.2 Market size and forecast, by Type
          • 7.3.5.2.3 Market size and forecast, by Application
          • 7.3.5.2.4 Market size and forecast, by Form
        • 7.3.5.3 Italy
          • 7.3.5.3.1 Key market trends, growth factors and opportunities
          • 7.3.5.3.2 Market size and forecast, by Type
          • 7.3.5.3.3 Market size and forecast, by Application
          • 7.3.5.3.4 Market size and forecast, by Form
        • 7.3.5.4 Spain
          • 7.3.5.4.1 Key market trends, growth factors and opportunities
          • 7.3.5.4.2 Market size and forecast, by Type
          • 7.3.5.4.3 Market size and forecast, by Application
          • 7.3.5.4.4 Market size and forecast, by Form
        • 7.3.5.5 UK
          • 7.3.5.5.1 Key market trends, growth factors and opportunities
          • 7.3.5.5.2 Market size and forecast, by Type
          • 7.3.5.5.3 Market size and forecast, by Application
          • 7.3.5.5.4 Market size and forecast, by Form
        • 7.3.5.6 Rest of Europe
          • 7.3.5.6.1 Key market trends, growth factors and opportunities
          • 7.3.5.6.2 Market size and forecast, by Type
          • 7.3.5.6.3 Market size and forecast, by Application
          • 7.3.5.6.4 Market size and forecast, by Form
    • 7.4 Asia-Pacific

      • 7.4.1 Key trends and opportunities

      • 7.4.2 Asia-Pacific Market size and forecast, by Type

        • 7.4.2.1 Asia-Pacific Sodium ascorbate Ascorbic Acid Market by Sub-type
        • 7.4.2.2 Asia-Pacific Potassium Ascorbate Ascorbic Acid Market by Sub-type
        • 7.4.2.3 Asia-Pacific Calcium Ascorbate Ascorbic Acid Market by Sub-type
        • 7.4.2.4 Asia-Pacific Magnesium Ascorbate Ascorbic Acid Market by Sub-type
        • 7.4.2.5 Asia-Pacific Others Ascorbic Acid Market by Sub-type
      • 7.4.3 Asia-Pacific Market size and forecast, by Application

      • 7.4.4 Asia-Pacific Market size and forecast, by Form

      • 7.4.5 Asia-Pacific Market size and forecast, by country

        • 7.4.5.1 China
          • 7.4.5.1.1 Key market trends, growth factors and opportunities
          • 7.4.5.1.2 Market size and forecast, by Type
          • 7.4.5.1.3 Market size and forecast, by Application
          • 7.4.5.1.4 Market size and forecast, by Form
        • 7.4.5.2 Japan
          • 7.4.5.2.1 Key market trends, growth factors and opportunities
          • 7.4.5.2.2 Market size and forecast, by Type
          • 7.4.5.2.3 Market size and forecast, by Application
          • 7.4.5.2.4 Market size and forecast, by Form
        • 7.4.5.3 India
          • 7.4.5.3.1 Key market trends, growth factors and opportunities
          • 7.4.5.3.2 Market size and forecast, by Type
          • 7.4.5.3.3 Market size and forecast, by Application
          • 7.4.5.3.4 Market size and forecast, by Form
        • 7.4.5.4 South Korea
          • 7.4.5.4.1 Key market trends, growth factors and opportunities
          • 7.4.5.4.2 Market size and forecast, by Type
          • 7.4.5.4.3 Market size and forecast, by Application
          • 7.4.5.4.4 Market size and forecast, by Form
        • 7.4.5.5 Australia
          • 7.4.5.5.1 Key market trends, growth factors and opportunities
          • 7.4.5.5.2 Market size and forecast, by Type
          • 7.4.5.5.3 Market size and forecast, by Application
          • 7.4.5.5.4 Market size and forecast, by Form
        • 7.4.5.6 Rest of Asia-Pacific
          • 7.4.5.6.1 Key market trends, growth factors and opportunities
          • 7.4.5.6.2 Market size and forecast, by Type
          • 7.4.5.6.3 Market size and forecast, by Application
          • 7.4.5.6.4 Market size and forecast, by Form
    • 7.5 LAMEA

      • 7.5.1 Key trends and opportunities

      • 7.5.2 LAMEA Market size and forecast, by Type

        • 7.5.2.1 LAMEA Sodium ascorbate Ascorbic Acid Market by Sub-type
        • 7.5.2.2 LAMEA Potassium Ascorbate Ascorbic Acid Market by Sub-type
        • 7.5.2.3 LAMEA Calcium Ascorbate Ascorbic Acid Market by Sub-type
        • 7.5.2.4 LAMEA Magnesium Ascorbate Ascorbic Acid Market by Sub-type
        • 7.5.2.5 LAMEA Others Ascorbic Acid Market by Sub-type
      • 7.5.3 LAMEA Market size and forecast, by Application

      • 7.5.4 LAMEA Market size and forecast, by Form

      • 7.5.5 LAMEA Market size and forecast, by country

        • 7.5.5.1 Latin America
          • 7.5.5.1.1 Key market trends, growth factors and opportunities
          • 7.5.5.1.2 Market size and forecast, by Type
          • 7.5.5.1.3 Market size and forecast, by Application
          • 7.5.5.1.4 Market size and forecast, by Form
        • 7.5.5.2 Middle East
          • 7.5.5.2.1 Key market trends, growth factors and opportunities
          • 7.5.5.2.2 Market size and forecast, by Type
          • 7.5.5.2.3 Market size and forecast, by Application
          • 7.5.5.2.4 Market size and forecast, by Form
        • 7.5.5.3 Africa
          • 7.5.5.3.1 Key market trends, growth factors and opportunities
          • 7.5.5.3.2 Market size and forecast, by Type
          • 7.5.5.3.3 Market size and forecast, by Application
          • 7.5.5.3.4 Market size and forecast, by Form
  • CHAPTER 8: COMPANY LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top winning strategies

    • 8.3. Product Mapping of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top player positioning, 2021

  • CHAPTER 9: COMPANY PROFILES

    • 9.1 Koninklijke DSM N.V.

      • 9.1.1 Company overview

      • 9.1.2 Key Executives

      • 9.1.3 Company snapshot

      • 9.1.4 Operating business segments

      • 9.1.5 Product portfolio

      • 9.1.6 Business performance

      • 9.1.7 Key strategic moves and developments

    • 9.2 CSPC Pharmaceutical Group Limited

      • 9.2.1 Company overview

      • 9.2.2 Key Executives

      • 9.2.3 Company snapshot

      • 9.2.4 Operating business segments

      • 9.2.5 Product portfolio

      • 9.2.6 Business performance

      • 9.2.7 Key strategic moves and developments

    • 9.3 MUBY CHEMICALS

      • 9.3.1 Company overview

      • 9.3.2 Key Executives

      • 9.3.3 Company snapshot

      • 9.3.4 Operating business segments

      • 9.3.5 Product portfolio

      • 9.3.6 Business performance

      • 9.3.7 Key strategic moves and developments

    • 9.4 Northeast Pharmaceutical Group Co., Ltd.

      • 9.4.1 Company overview

      • 9.4.2 Key Executives

      • 9.4.3 Company snapshot

      • 9.4.4 Operating business segments

      • 9.4.5 Product portfolio

      • 9.4.6 Business performance

      • 9.4.7 Key strategic moves and developments

    • 9.5 Luwei Pharmaceutical Group Co., Ltd

      • 9.5.1 Company overview

      • 9.5.2 Key Executives

      • 9.5.3 Company snapshot

      • 9.5.4 Operating business segments

      • 9.5.5 Product portfolio

      • 9.5.6 Business performance

      • 9.5.7 Key strategic moves and developments

    • 9.6 ACP Chemicals Inc

      • 9.6.1 Company overview

      • 9.6.2 Key Executives

      • 9.6.3 Company snapshot

      • 9.6.4 Operating business segments

      • 9.6.5 Product portfolio

      • 9.6.6 Business performance

      • 9.6.7 Key strategic moves and developments

    • 9.7 Merck KGaA

      • 9.7.1 Company overview

      • 9.7.2 Key Executives

      • 9.7.3 Company snapshot

      • 9.7.4 Operating business segments

      • 9.7.5 Product portfolio

      • 9.7.6 Business performance

      • 9.7.7 Key strategic moves and developments

    • 9.8 Foodchem International Corporation

      • 9.8.1 Company overview

      • 9.8.2 Key Executives

      • 9.8.3 Company snapshot

      • 9.8.4 Operating business segments

      • 9.8.5 Product portfolio

      • 9.8.6 Business performance

      • 9.8.7 Key strategic moves and developments

    • 9.9 Blagden Speciality Chemicals Ltd.

      • 9.9.1 Company overview

      • 9.9.2 Key Executives

      • 9.9.3 Company snapshot

      • 9.9.4 Operating business segments

      • 9.9.5 Product portfolio

      • 9.9.6 Business performance

      • 9.9.7 Key strategic moves and developments

    • 9.10 Bactolac Pharmaceutical Inc.

      • 9.10.1 Company overview

      • 9.10.2 Key Executives

      • 9.10.3 Company snapshot

      • 9.10.4 Operating business segments

      • 9.10.5 Product portfolio

      • 9.10.6 Business performance

      • 9.10.7 Key strategic moves and developments

    • 9.11 Aland Health Holding Ltd

      • 9.11.1 Company overview

      • 9.11.2 Key Executives

      • 9.11.3 Company snapshot

      • 9.11.4 Operating business segments

      • 9.11.5 Product portfolio

      • 9.11.6 Business performance

      • 9.11.7 Key strategic moves and developments

    • 9.12 FUJIFILM Corporation

      • 9.12.1 Company overview

      • 9.12.2 Key Executives

      • 9.12.3 Company snapshot

      • 9.12.4 Operating business segments

      • 9.12.5 Product portfolio

      • 9.12.6 Business performance

      • 9.12.7 Key strategic moves and developments

    • 9.13 Medisca Inc.

      • 9.13.1 Company overview

      • 9.13.2 Key Executives

      • 9.13.3 Company snapshot

      • 9.13.4 Operating business segments

      • 9.13.5 Product portfolio

      • 9.13.6 Business performance

      • 9.13.7 Key strategic moves and developments

    • 9.14 Superior Supplement Manufacturing

      • 9.14.1 Company overview

      • 9.14.2 Key Executives

      • 9.14.3 Company snapshot

      • 9.14.4 Operating business segments

      • 9.14.5 Product portfolio

      • 9.14.6 Business performance

      • 9.14.7 Key strategic moves and developments

    • 9.15 Pharmavit

      • 9.15.1 Company overview

      • 9.15.2 Key Executives

      • 9.15.3 Company snapshot

      • 9.15.4 Operating business segments

      • 9.15.5 Product portfolio

      • 9.15.6 Business performance

      • 9.15.7 Key strategic moves and developments

    • 9.16 Reckon Organics Private Ltd.

      • 9.16.1 Company overview

      • 9.16.2 Key Executives

      • 9.16.3 Company snapshot

      • 9.16.4 Operating business segments

      • 9.16.5 Product portfolio

      • 9.16.6 Business performance

      • 9.16.7 Key strategic moves and developments

    • 9.17 Chemceed

      • 9.17.1 Company overview

      • 9.17.2 Key Executives

      • 9.17.3 Company snapshot

      • 9.17.4 Operating business segments

      • 9.17.5 Product portfolio

      • 9.17.6 Business performance

      • 9.17.7 Key strategic moves and developments

    • 9.18 Botanic Healthcare

      • 9.18.1 Company overview

      • 9.18.2 Key Executives

      • 9.18.3 Company snapshot

      • 9.18.4 Operating business segments

      • 9.18.5 Product portfolio

      • 9.18.6 Business performance

      • 9.18.7 Key strategic moves and developments

    • 9.19  Vega Group company limited

      • 9.19.1 Company overview

      • 9.19.2 Key Executives

      • 9.19.3 Company snapshot

      • 9.19.4 Operating business segments

      • 9.19.5 Product portfolio

      • 9.19.6 Business performance

      • 9.19.7 Key strategic moves and developments

    • 9.20 Glanbia PLC

      • 9.20.1 Company overview

      • 9.20.2 Key Executives

      • 9.20.3 Company snapshot

      • 9.20.4 Operating business segments

      • 9.20.5 Product portfolio

      • 9.20.6 Business performance

      • 9.20.7 Key strategic moves and developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL ASCORBIC ACID MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 2. GLOBAL ASCORBIC ACID MARKET, BY TYPE, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 3. ASCORBIC ACID MARKET FOR SODIUM ASCORBATE, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 4. ASCORBIC ACID MARKET FOR SODIUM ASCORBATE, BY REGION, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 5. GLOBAL SODIUM ASCORBATE ASCORBIC ACID MARKET, BY SUB-TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 6. GLOBAL SODIUM ASCORBATE ASCORBIC ACID MARKET, BY SUB-TYPE, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 7. ASCORBIC ACID MARKET FOR FLAVORED, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 8. ASCORBIC ACID MARKET FOR FLAVORED, BY REGION, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 9. ASCORBIC ACID MARKET FOR UNFLAVORED, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 10. ASCORBIC ACID MARKET FOR UNFLAVORED, BY REGION, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 11. ASCORBIC ACID MARKET FOR POTASSIUM ASCORBATE, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 12. ASCORBIC ACID MARKET FOR POTASSIUM ASCORBATE, BY REGION, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 13. GLOBAL POTASSIUM ASCORBATE ASCORBIC ACID MARKET, BY SUB-TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 14. GLOBAL POTASSIUM ASCORBATE ASCORBIC ACID MARKET, BY SUB-TYPE, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 15. ASCORBIC ACID MARKET FOR FLAVORED, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 16. ASCORBIC ACID MARKET FOR FLAVORED, BY REGION, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 17. ASCORBIC ACID MARKET FOR UNFLAVORED, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 18. ASCORBIC ACID MARKET FOR UNFLAVORED, BY REGION, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 19. ASCORBIC ACID MARKET FOR CALCIUM ASCORBATE, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 20. ASCORBIC ACID MARKET FOR CALCIUM ASCORBATE, BY REGION, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 21. GLOBAL CALCIUM ASCORBATE ASCORBIC ACID MARKET, BY SUB-TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 22. GLOBAL CALCIUM ASCORBATE ASCORBIC ACID MARKET, BY SUB-TYPE, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 23. ASCORBIC ACID MARKET FOR FLAVORED, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 24. ASCORBIC ACID MARKET FOR FLAVORED, BY REGION, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 25. ASCORBIC ACID MARKET FOR UNFLAVORED, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 26. ASCORBIC ACID MARKET FOR UNFLAVORED, BY REGION, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 27. ASCORBIC ACID MARKET FOR MAGNESIUM ASCORBATE, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 28. ASCORBIC ACID MARKET FOR MAGNESIUM ASCORBATE, BY REGION, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 29. GLOBAL MAGNESIUM ASCORBATE ASCORBIC ACID MARKET, BY SUB-TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 30. GLOBAL MAGNESIUM ASCORBATE ASCORBIC ACID MARKET, BY SUB-TYPE, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 31. ASCORBIC ACID MARKET FOR FLAVORED, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 32. ASCORBIC ACID MARKET FOR FLAVORED, BY REGION, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 33. ASCORBIC ACID MARKET FOR UNFLAVORED, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 34. ASCORBIC ACID MARKET FOR UNFLAVORED, BY REGION, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 35. ASCORBIC ACID MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 36. ASCORBIC ACID MARKET FOR OTHERS, BY REGION, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 37. GLOBAL OTHERS ASCORBIC ACID MARKET, BY SUB-TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 38. GLOBAL OTHERS ASCORBIC ACID MARKET, BY SUB-TYPE, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 39. ASCORBIC ACID MARKET FOR FLAVORED, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 40. ASCORBIC ACID MARKET FOR FLAVORED, BY REGION, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 41. ASCORBIC ACID MARKET FOR UNFLAVORED, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 42. ASCORBIC ACID MARKET FOR UNFLAVORED, BY REGION, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 43. GLOBAL ASCORBIC ACID MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 44. ASCORBIC ACID MARKET FOR FOOD AND BEVERAGES, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 45. ASCORBIC ACID MARKET FOR PHARMACEUTICAL, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 46. ASCORBIC ACID MARKET FOR BEAUTY AND PERSONAL CARE, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 47. ASCORBIC ACID MARKET FOR ANIMAL FEED, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 48. GLOBAL ASCORBIC ACID MARKET, BY FORM, 2021-2031 (REVENUE, $MILLION)
    TABLE 49. ASCORBIC ACID MARKET FOR POWDER, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 50. ASCORBIC ACID MARKET FOR LIQUID, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 51. ASCORBIC ACID MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 52. ASCORBIC ACID MARKET, BY REGION, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 53. NORTH AMERICA ASCORBIC ACID MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 54. NORTH AMERICA ASCORBIC ACID MARKET, BY TYPE, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 55. NORTH AMERICA SODIUM ASCORBATE ASCORBIC ACID MARKET, BY SUB-TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 56. NORTH AMERICA SODIUM ASCORBATE ASCORBIC ACID MARKET, BY SUB-TYPE, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 57. NORTH AMERICA POTASSIUM ASCORBATE ASCORBIC ACID MARKET, BY SUB-TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 58. NORTH AMERICA POTASSIUM ASCORBATE ASCORBIC ACID MARKET, BY SUB-TYPE, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 59. NORTH AMERICA CALCIUM ASCORBATE ASCORBIC ACID MARKET, BY SUB-TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 60. NORTH AMERICA CALCIUM ASCORBATE ASCORBIC ACID MARKET, BY SUB-TYPE, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 61. NORTH AMERICA MAGNESIUM ASCORBATE ASCORBIC ACID MARKET, BY SUB-TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 62. NORTH AMERICA MAGNESIUM ASCORBATE ASCORBIC ACID MARKET, BY SUB-TYPE, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 63. NORTH AMERICA OTHERS ASCORBIC ACID MARKET, BY SUB-TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 64. NORTH AMERICA OTHERS ASCORBIC ACID MARKET, BY SUB-TYPE, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 65. NORTH AMERICA ASCORBIC ACID MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 66. NORTH AMERICA ASCORBIC ACID MARKET, BY FORM, 2021-2031 (REVENUE, $MILLION)
    TABLE 67. NORTH AMERICA ASCORBIC ACID MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
    TABLE 68. NORTH AMERICA ASCORBIC ACID MARKET, BY COUNTRY, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 69. U.S. ASCORBIC ACID MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 70. U.S. ASCORBIC ACID MARKET, BY TYPE, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 71. U.S. ASCORBIC ACID MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 72. U.S. ASCORBIC ACID MARKET, BY FORM, 2021-2031 (REVENUE, $MILLION)
    TABLE 73. CANADA ASCORBIC ACID MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 74. CANADA ASCORBIC ACID MARKET, BY TYPE, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 75. CANADA ASCORBIC ACID MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 76. CANADA ASCORBIC ACID MARKET, BY FORM, 2021-2031 (REVENUE, $MILLION)
    TABLE 77. MEXICO ASCORBIC ACID MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 78. MEXICO ASCORBIC ACID MARKET, BY TYPE, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 79. MEXICO ASCORBIC ACID MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 80. MEXICO ASCORBIC ACID MARKET, BY FORM, 2021-2031 (REVENUE, $MILLION)
    TABLE 81. EUROPE ASCORBIC ACID MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 82. EUROPE ASCORBIC ACID MARKET, BY TYPE, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 83. EUROPE SODIUM ASCORBATE ASCORBIC ACID MARKET, BY SUB-TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 84. EUROPE SODIUM ASCORBATE ASCORBIC ACID MARKET, BY SUB-TYPE, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 85. EUROPE POTASSIUM ASCORBATE ASCORBIC ACID MARKET, BY SUB-TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 86. EUROPE POTASSIUM ASCORBATE ASCORBIC ACID MARKET, BY SUB-TYPE, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 87. EUROPE CALCIUM ASCORBATE ASCORBIC ACID MARKET, BY SUB-TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 88. EUROPE CALCIUM ASCORBATE ASCORBIC ACID MARKET, BY SUB-TYPE, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 89. EUROPE MAGNESIUM ASCORBATE ASCORBIC ACID MARKET, BY SUB-TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 90. EUROPE MAGNESIUM ASCORBATE ASCORBIC ACID MARKET, BY SUB-TYPE, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 91. EUROPE OTHERS ASCORBIC ACID MARKET, BY SUB-TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 92. EUROPE OTHERS ASCORBIC ACID MARKET, BY SUB-TYPE, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 93. EUROPE ASCORBIC ACID MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 94. EUROPE ASCORBIC ACID MARKET, BY FORM, 2021-2031 (REVENUE, $MILLION)
    TABLE 95. EUROPE ASCORBIC ACID MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
    TABLE 96. EUROPE ASCORBIC ACID MARKET, BY COUNTRY, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 97. FRANCE ASCORBIC ACID MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 98. FRANCE ASCORBIC ACID MARKET, BY TYPE, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 99. FRANCE ASCORBIC ACID MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 100. FRANCE ASCORBIC ACID MARKET, BY FORM, 2021-2031 (REVENUE, $MILLION)
    TABLE 101. GERMANY ASCORBIC ACID MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 102. GERMANY ASCORBIC ACID MARKET, BY TYPE, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 103. GERMANY ASCORBIC ACID MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 104. GERMANY ASCORBIC ACID MARKET, BY FORM, 2021-2031 (REVENUE, $MILLION)
    TABLE 105. ITALY ASCORBIC ACID MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 106. ITALY ASCORBIC ACID MARKET, BY TYPE, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 107. ITALY ASCORBIC ACID MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 108. ITALY ASCORBIC ACID MARKET, BY FORM, 2021-2031 (REVENUE, $MILLION)
    TABLE 109. SPAIN ASCORBIC ACID MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 110. SPAIN ASCORBIC ACID MARKET, BY TYPE, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 111. SPAIN ASCORBIC ACID MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 112. SPAIN ASCORBIC ACID MARKET, BY FORM, 2021-2031 (REVENUE, $MILLION)
    TABLE 113. UK ASCORBIC ACID MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 114. UK ASCORBIC ACID MARKET, BY TYPE, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 115. UK ASCORBIC ACID MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 116. UK ASCORBIC ACID MARKET, BY FORM, 2021-2031 (REVENUE, $MILLION)
    TABLE 117. REST OF EUROPE ASCORBIC ACID MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 118. REST OF EUROPE ASCORBIC ACID MARKET, BY TYPE, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 119. REST OF EUROPE ASCORBIC ACID MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 120. REST OF EUROPE ASCORBIC ACID MARKET, BY FORM, 2021-2031 (REVENUE, $MILLION)
    TABLE 121. ASIA-PACIFIC ASCORBIC ACID MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 122. ASIA-PACIFIC ASCORBIC ACID MARKET, BY TYPE, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 123. ASIA-PACIFIC SODIUM ASCORBATE ASCORBIC ACID MARKET, BY SUB-TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 124. ASIA-PACIFIC SODIUM ASCORBATE ASCORBIC ACID MARKET, BY SUB-TYPE, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 125. ASIA-PACIFIC POTASSIUM ASCORBATE ASCORBIC ACID MARKET, BY SUB-TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 126. ASIA-PACIFIC POTASSIUM ASCORBATE ASCORBIC ACID MARKET, BY SUB-TYPE, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 127. ASIA-PACIFIC CALCIUM ASCORBATE ASCORBIC ACID MARKET, BY SUB-TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 128. ASIA-PACIFIC CALCIUM ASCORBATE ASCORBIC ACID MARKET, BY SUB-TYPE, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 129. ASIA-PACIFIC MAGNESIUM ASCORBATE ASCORBIC ACID MARKET, BY SUB-TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 130. ASIA-PACIFIC MAGNESIUM ASCORBATE ASCORBIC ACID MARKET, BY SUB-TYPE, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 131. ASIA-PACIFIC OTHERS ASCORBIC ACID MARKET, BY SUB-TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 132. ASIA-PACIFIC OTHERS ASCORBIC ACID MARKET, BY SUB-TYPE, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 133. ASIA-PACIFIC ASCORBIC ACID MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 134. ASIA-PACIFIC ASCORBIC ACID MARKET, BY FORM, 2021-2031 (REVENUE, $MILLION)
    TABLE 135. ASIA-PACIFIC ASCORBIC ACID MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
    TABLE 136. ASIA-PACIFIC ASCORBIC ACID MARKET, BY COUNTRY, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 137. CHINA ASCORBIC ACID MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 138. CHINA ASCORBIC ACID MARKET, BY TYPE, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 139. CHINA ASCORBIC ACID MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 140. CHINA ASCORBIC ACID MARKET, BY FORM, 2021-2031 (REVENUE, $MILLION)
    TABLE 141. JAPAN ASCORBIC ACID MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 142. JAPAN ASCORBIC ACID MARKET, BY TYPE, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 143. JAPAN ASCORBIC ACID MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 144. JAPAN ASCORBIC ACID MARKET, BY FORM, 2021-2031 (REVENUE, $MILLION)
    TABLE 145. INDIA ASCORBIC ACID MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 146. INDIA ASCORBIC ACID MARKET, BY TYPE, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 147. INDIA ASCORBIC ACID MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 148. INDIA ASCORBIC ACID MARKET, BY FORM, 2021-2031 (REVENUE, $MILLION)
    TABLE 149. SOUTH KOREA ASCORBIC ACID MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 150. SOUTH KOREA ASCORBIC ACID MARKET, BY TYPE, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 151. SOUTH KOREA ASCORBIC ACID MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 152. SOUTH KOREA ASCORBIC ACID MARKET, BY FORM, 2021-2031 (REVENUE, $MILLION)
    TABLE 153. AUSTRALIA ASCORBIC ACID MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 154. AUSTRALIA ASCORBIC ACID MARKET, BY TYPE, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 155. AUSTRALIA ASCORBIC ACID MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 156. AUSTRALIA ASCORBIC ACID MARKET, BY FORM, 2021-2031 (REVENUE, $MILLION)
    TABLE 157. REST OF ASIA-PACIFIC ASCORBIC ACID MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 158. REST OF ASIA-PACIFIC ASCORBIC ACID MARKET, BY TYPE, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 159. REST OF ASIA-PACIFIC ASCORBIC ACID MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 160. REST OF ASIA-PACIFIC ASCORBIC ACID MARKET, BY FORM, 2021-2031 (REVENUE, $MILLION)
    TABLE 161. LAMEA ASCORBIC ACID MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 162. LAMEA ASCORBIC ACID MARKET, BY TYPE, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 163. LAMEA SODIUM ASCORBATE ASCORBIC ACID MARKET, BY SUB-TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 164. LAMEA SODIUM ASCORBATE ASCORBIC ACID MARKET, BY SUB-TYPE, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 165. LAMEA POTASSIUM ASCORBATE ASCORBIC ACID MARKET, BY SUB-TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 166. LAMEA POTASSIUM ASCORBATE ASCORBIC ACID MARKET, BY SUB-TYPE, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 167. LAMEA CALCIUM ASCORBATE ASCORBIC ACID MARKET, BY SUB-TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 168. LAMEA CALCIUM ASCORBATE ASCORBIC ACID MARKET, BY SUB-TYPE, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 169. LAMEA MAGNESIUM ASCORBATE ASCORBIC ACID MARKET, BY SUB-TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 170. LAMEA MAGNESIUM ASCORBATE ASCORBIC ACID MARKET, BY SUB-TYPE, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 171. LAMEA OTHERS ASCORBIC ACID MARKET, BY SUB-TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 172. LAMEA OTHERS ASCORBIC ACID MARKET, BY SUB-TYPE, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 173. LAMEA ASCORBIC ACID MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 174. LAMEA ASCORBIC ACID MARKET, BY FORM, 2021-2031 (REVENUE, $MILLION)
    TABLE 175. LAMEA ASCORBIC ACID MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
    TABLE 176. LAMEA ASCORBIC ACID MARKET, BY COUNTRY, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 177. LATIN AMERICA ASCORBIC ACID MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 178. LATIN AMERICA ASCORBIC ACID MARKET, BY TYPE, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 179. LATIN AMERICA ASCORBIC ACID MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 180. LATIN AMERICA ASCORBIC ACID MARKET, BY FORM, 2021-2031 (REVENUE, $MILLION)
    TABLE 181. MIDDLE EAST ASCORBIC ACID MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 182. MIDDLE EAST ASCORBIC ACID MARKET, BY TYPE, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 183. MIDDLE EAST ASCORBIC ACID MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 184. MIDDLE EAST ASCORBIC ACID MARKET, BY FORM, 2021-2031 (REVENUE, $MILLION)
    TABLE 185. AFRICA ASCORBIC ACID MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 186. AFRICA ASCORBIC ACID MARKET, BY TYPE, 2021-2031 (VOLUME, MILLION TONS)
    TABLE 187. AFRICA ASCORBIC ACID MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 188. AFRICA ASCORBIC ACID MARKET, BY FORM, 2021-2031 (REVENUE, $MILLION)
    TABLE 189.KONINKLIJKE DSM N.V.: KEY EXECUTIVES
    TABLE 189.KONINKLIJKE DSM N.V.: COMPANY SNAPSHOT
    TABLE 190.KONINKLIJKE DSM N.V.: OPERATING SEGMENTS
    TABLE 191.KONINKLIJKE DSM N.V.: PRODUCT PORTFOLIO
    TABLE 192.KONINKLIJKE DSM N.V.: NET SALES
    TABLE 193.KONINKLIJKE DSM N.V.: KEY STRATERGIES
    TABLE 195.CSPC PHARMACEUTICAL GROUP LIMITED: KEY EXECUTIVES
    TABLE 195.CSPC PHARMACEUTICAL GROUP LIMITED: COMPANY SNAPSHOT
    TABLE 196.CSPC PHARMACEUTICAL GROUP LIMITED: OPERATING SEGMENTS
    TABLE 197.CSPC PHARMACEUTICAL GROUP LIMITED: PRODUCT PORTFOLIO
    TABLE 198.CSPC PHARMACEUTICAL GROUP LIMITED: NET SALES
    TABLE 199.CSPC PHARMACEUTICAL GROUP LIMITED: KEY STRATERGIES
    TABLE 201.MUBY CHEMICALS: KEY EXECUTIVES
    TABLE 201.MUBY CHEMICALS: COMPANY SNAPSHOT
    TABLE 202.MUBY CHEMICALS: OPERATING SEGMENTS
    TABLE 203.MUBY CHEMICALS: PRODUCT PORTFOLIO
    TABLE 204.MUBY CHEMICALS: NET SALES
    TABLE 205.MUBY CHEMICALS: KEY STRATERGIES
    TABLE 207.NORTHEAST PHARMACEUTICAL GROUP CO., LTD.: KEY EXECUTIVES
    TABLE 207.NORTHEAST PHARMACEUTICAL GROUP CO., LTD.: COMPANY SNAPSHOT
    TABLE 208.NORTHEAST PHARMACEUTICAL GROUP CO., LTD.: OPERATING SEGMENTS
    TABLE 209.NORTHEAST PHARMACEUTICAL GROUP CO., LTD.: PRODUCT PORTFOLIO
    TABLE 210.NORTHEAST PHARMACEUTICAL GROUP CO., LTD.: NET SALES
    TABLE 211.NORTHEAST PHARMACEUTICAL GROUP CO., LTD.: KEY STRATERGIES
    TABLE 213.LUWEI PHARMACEUTICAL GROUP CO., LTD: KEY EXECUTIVES
    TABLE 213.LUWEI PHARMACEUTICAL GROUP CO., LTD: COMPANY SNAPSHOT
    TABLE 214.LUWEI PHARMACEUTICAL GROUP CO., LTD: OPERATING SEGMENTS
    TABLE 215.LUWEI PHARMACEUTICAL GROUP CO., LTD: PRODUCT PORTFOLIO
    TABLE 216.LUWEI PHARMACEUTICAL GROUP CO., LTD: NET SALES
    TABLE 217.LUWEI PHARMACEUTICAL GROUP CO., LTD: KEY STRATERGIES
    TABLE 219.ACP CHEMICALS INC: KEY EXECUTIVES
    TABLE 219.ACP CHEMICALS INC: COMPANY SNAPSHOT
    TABLE 220.ACP CHEMICALS INC: OPERATING SEGMENTS
    TABLE 221.ACP CHEMICALS INC: PRODUCT PORTFOLIO
    TABLE 222.ACP CHEMICALS INC: NET SALES
    TABLE 223.ACP CHEMICALS INC: KEY STRATERGIES
    TABLE 225.MERCK KGAA: KEY EXECUTIVES
    TABLE 225.MERCK KGAA: COMPANY SNAPSHOT
    TABLE 226.MERCK KGAA: OPERATING SEGMENTS
    TABLE 227.MERCK KGAA: PRODUCT PORTFOLIO
    TABLE 228.MERCK KGAA: NET SALES
    TABLE 229.MERCK KGAA: KEY STRATERGIES
    TABLE 231.FOODCHEM INTERNATIONAL CORPORATION: KEY EXECUTIVES
    TABLE 231.FOODCHEM INTERNATIONAL CORPORATION: COMPANY SNAPSHOT
    TABLE 232.FOODCHEM INTERNATIONAL CORPORATION: OPERATING SEGMENTS
    TABLE 233.FOODCHEM INTERNATIONAL CORPORATION: PRODUCT PORTFOLIO
    TABLE 234.FOODCHEM INTERNATIONAL CORPORATION: NET SALES
    TABLE 235.FOODCHEM INTERNATIONAL CORPORATION: KEY STRATERGIES
    TABLE 237.BLAGDEN SPECIALITY CHEMICALS LTD.: KEY EXECUTIVES
    TABLE 237.BLAGDEN SPECIALITY CHEMICALS LTD.: COMPANY SNAPSHOT
    TABLE 238.BLAGDEN SPECIALITY CHEMICALS LTD.: OPERATING SEGMENTS
    TABLE 239.BLAGDEN SPECIALITY CHEMICALS LTD.: PRODUCT PORTFOLIO
    TABLE 240.BLAGDEN SPECIALITY CHEMICALS LTD.: NET SALES
    TABLE 241.BLAGDEN SPECIALITY CHEMICALS LTD.: KEY STRATERGIES
    TABLE 243.BACTOLAC PHARMACEUTICAL INC.: KEY EXECUTIVES
    TABLE 243.BACTOLAC PHARMACEUTICAL INC.: COMPANY SNAPSHOT
    TABLE 244.BACTOLAC PHARMACEUTICAL INC.: OPERATING SEGMENTS
    TABLE 245.BACTOLAC PHARMACEUTICAL INC.: PRODUCT PORTFOLIO
    TABLE 246.BACTOLAC PHARMACEUTICAL INC.: NET SALES
    TABLE 247.BACTOLAC PHARMACEUTICAL INC.: KEY STRATERGIES
    TABLE 249.ALAND HEALTH HOLDING LTD: KEY EXECUTIVES
    TABLE 249.ALAND HEALTH HOLDING LTD: COMPANY SNAPSHOT
    TABLE 250.ALAND HEALTH HOLDING LTD: OPERATING SEGMENTS
    TABLE 251.ALAND HEALTH HOLDING LTD: PRODUCT PORTFOLIO
    TABLE 252.ALAND HEALTH HOLDING LTD: NET SALES
    TABLE 253.ALAND HEALTH HOLDING LTD: KEY STRATERGIES
    TABLE 255.FUJIFILM CORPORATION: KEY EXECUTIVES
    TABLE 255.FUJIFILM CORPORATION: COMPANY SNAPSHOT
    TABLE 256.FUJIFILM CORPORATION: OPERATING SEGMENTS
    TABLE 257.FUJIFILM CORPORATION: PRODUCT PORTFOLIO
    TABLE 258.FUJIFILM CORPORATION: NET SALES
    TABLE 259.FUJIFILM CORPORATION: KEY STRATERGIES
    TABLE 261.MEDISCA INC.: KEY EXECUTIVES
    TABLE 261.MEDISCA INC.: COMPANY SNAPSHOT
    TABLE 262.MEDISCA INC.: OPERATING SEGMENTS
    TABLE 263.MEDISCA INC.: PRODUCT PORTFOLIO
    TABLE 264.MEDISCA INC.: NET SALES
    TABLE 265.MEDISCA INC.: KEY STRATERGIES
    TABLE 267.SUPERIOR SUPPLEMENT MANUFACTURING: KEY EXECUTIVES
    TABLE 267.SUPERIOR SUPPLEMENT MANUFACTURING: COMPANY SNAPSHOT
    TABLE 268.SUPERIOR SUPPLEMENT MANUFACTURING: OPERATING SEGMENTS
    TABLE 269.SUPERIOR SUPPLEMENT MANUFACTURING: PRODUCT PORTFOLIO
    TABLE 270.SUPERIOR SUPPLEMENT MANUFACTURING: NET SALES
    TABLE 271.SUPERIOR SUPPLEMENT MANUFACTURING: KEY STRATERGIES
    TABLE 273.PHARMAVIT: KEY EXECUTIVES
    TABLE 273.PHARMAVIT: COMPANY SNAPSHOT
    TABLE 274.PHARMAVIT: OPERATING SEGMENTS
    TABLE 275.PHARMAVIT: PRODUCT PORTFOLIO
    TABLE 276.PHARMAVIT: NET SALES
    TABLE 277.PHARMAVIT: KEY STRATERGIES
    TABLE 279.RECKON ORGANICS PRIVATE LTD.: KEY EXECUTIVES
    TABLE 279.RECKON ORGANICS PRIVATE LTD.: COMPANY SNAPSHOT
    TABLE 280.RECKON ORGANICS PRIVATE LTD.: OPERATING SEGMENTS
    TABLE 281.RECKON ORGANICS PRIVATE LTD.: PRODUCT PORTFOLIO
    TABLE 282.RECKON ORGANICS PRIVATE LTD.: NET SALES
    TABLE 283.RECKON ORGANICS PRIVATE LTD.: KEY STRATERGIES
    TABLE 285.CHEMCEED: KEY EXECUTIVES
    TABLE 285.CHEMCEED: COMPANY SNAPSHOT
    TABLE 286.CHEMCEED: OPERATING SEGMENTS
    TABLE 287.CHEMCEED: PRODUCT PORTFOLIO
    TABLE 288.CHEMCEED: NET SALES
    TABLE 289.CHEMCEED: KEY STRATERGIES
    TABLE 291.BOTANIC HEALTHCARE: KEY EXECUTIVES
    TABLE 291.BOTANIC HEALTHCARE: COMPANY SNAPSHOT
    TABLE 292.BOTANIC HEALTHCARE: OPERATING SEGMENTS
    TABLE 293.BOTANIC HEALTHCARE: PRODUCT PORTFOLIO
    TABLE 294.BOTANIC HEALTHCARE: NET SALES
    TABLE 295.BOTANIC HEALTHCARE: KEY STRATERGIES
    TABLE 297. VEGA GROUP COMPANY LIMITED: KEY EXECUTIVES
    TABLE 297. VEGA GROUP COMPANY LIMITED: COMPANY SNAPSHOT
    TABLE 298. VEGA GROUP COMPANY LIMITED: OPERATING SEGMENTS
    TABLE 299. VEGA GROUP COMPANY LIMITED: PRODUCT PORTFOLIO
    TABLE 300. VEGA GROUP COMPANY LIMITED: NET SALES
    TABLE 301. VEGA GROUP COMPANY LIMITED: KEY STRATERGIES
    TABLE 303.GLANBIA PLC: KEY EXECUTIVES
    TABLE 303.GLANBIA PLC: COMPANY SNAPSHOT
    TABLE 304.GLANBIA PLC: OPERATING SEGMENTS
    TABLE 305.GLANBIA PLC: PRODUCT PORTFOLIO
    TABLE 306.GLANBIA PLC: NET SALES
    TABLE 307.GLANBIA PLC: KEY STRATERGIES
  • LIST OF FIGURES

  • FIGURE 1. SEGMENTATION OF ASCORBIC ACID MARKET,2021-2031
    FIGURE 2.ASCORBIC ACID MARKET,2021-2031
    FIGURE 3. TOP INVESTMENT POCKETS, BY REGION
    FIGURE 4.PORTER FIVE-1
    FIGURE 5.PORTER FIVE-2
    FIGURE 6.PORTER FIVE-3
    FIGURE 7.PORTER FIVE-4
    FIGURE 8.PORTER FIVE-5
    FIGURE 9.ASCORBIC ACID MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
    FIGURE 10.REGULATORY GUIDELINES
    FIGURE 11.ASCORBIC ACID MARKET,BY TYPE,2021(%)
    FIGURE 12.COMPARATIVE SHARE ANALYSIS OF SODIUM ASCORBATE ASCORBIC ACID MARKET, 2021 AND 2031(%)
    FIGURE 13.COMPARATIVE SHARE ANALYSIS OF POTASSIUM ASCORBATE ASCORBIC ACID MARKET, 2021 AND 2031(%)
    FIGURE 14.COMPARATIVE SHARE ANALYSIS OF CALCIUM ASCORBATE ASCORBIC ACID MARKET, 2021 AND 2031(%)
    FIGURE 15.COMPARATIVE SHARE ANALYSIS OF MAGNESIUM ASCORBATE ASCORBIC ACID MARKET, 2021 AND 2031(%)
    FIGURE 16.COMPARATIVE SHARE ANALYSIS OF OTHERS ASCORBIC ACID MARKET, 2021 AND 2031(%)
    FIGURE 17.ASCORBIC ACID MARKET,BY APPLICATION,2021(%)
    FIGURE 18.COMPARATIVE SHARE ANALYSIS OF FOOD AND BEVERAGES ASCORBIC ACID MARKET, 2021 AND 2031(%)
    FIGURE 19.COMPARATIVE SHARE ANALYSIS OF PHARMACEUTICAL ASCORBIC ACID MARKET, 2021 AND 2031(%)
    FIGURE 20.COMPARATIVE SHARE ANALYSIS OF BEAUTY AND PERSONAL CARE ASCORBIC ACID MARKET, 2021 AND 2031(%)
    FIGURE 21.COMPARATIVE SHARE ANALYSIS OF ANIMAL FEED ASCORBIC ACID MARKET, 2021 AND 2031(%)
    FIGURE 22.ASCORBIC ACID MARKET,BY FORM,2021(%)
    FIGURE 23.COMPARATIVE SHARE ANALYSIS OF POWDER ASCORBIC ACID MARKET, 2021 AND 2031(%)
    FIGURE 24.COMPARATIVE SHARE ANALYSIS OF LIQUID ASCORBIC ACID MARKET, 2021 AND 2031(%)
    FIGURE 25.ASCORBIC ACID MARKET BY REGION,2021
    FIGURE 26.U.S. ASCORBIC ACID MARKET,2021-2031($MILLION)
    FIGURE 27.CANADA ASCORBIC ACID MARKET,2021-2031($MILLION)
    FIGURE 28.MEXICO ASCORBIC ACID MARKET,2021-2031($MILLION)
    FIGURE 29.FRANCE ASCORBIC ACID MARKET,2021-2031($MILLION)
    FIGURE 30.GERMANY ASCORBIC ACID MARKET,2021-2031($MILLION)
    FIGURE 31.ITALY ASCORBIC ACID MARKET,2021-2031($MILLION)
    FIGURE 32.SPAIN ASCORBIC ACID MARKET,2021-2031($MILLION)
    FIGURE 33.UK ASCORBIC ACID MARKET,2021-2031($MILLION)
    FIGURE 34.REST OF EUROPE ASCORBIC ACID MARKET,2021-2031($MILLION)
    FIGURE 35.CHINA ASCORBIC ACID MARKET,2021-2031($MILLION)
    FIGURE 36.JAPAN ASCORBIC ACID MARKET,2021-2031($MILLION)
    FIGURE 37.INDIA ASCORBIC ACID MARKET,2021-2031($MILLION)
    FIGURE 38.SOUTH KOREA ASCORBIC ACID MARKET,2021-2031($MILLION)
    FIGURE 39.AUSTRALIA ASCORBIC ACID MARKET,2021-2031($MILLION)
    FIGURE 40.REST OF ASIA-PACIFIC ASCORBIC ACID MARKET,2021-2031($MILLION)
    FIGURE 41.LATIN AMERICA ASCORBIC ACID MARKET,2021-2031($MILLION)
    FIGURE 42.MIDDLE EAST ASCORBIC ACID MARKET,2021-2031($MILLION)
    FIGURE 43.AFRICA ASCORBIC ACID MARKET,2021-2031($MILLION)
    FIGURE 44. TOP WINNING STRATEGIES, BY YEAR
    FIGURE 45. TOP WINNING STRATEGIES, BY DEVELOPMENT
    FIGURE 46. TOP WINNING STRATEGIES, BY COMPANY
    FIGURE 47.PRODUCT MAPPING OF TOP 10 PLAYERS
    FIGURE 48.COMPETITIVE DASHBOARD
    FIGURE 49.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
    FIGURE 50.TOP PLAYER POSITIONING, 2021
    FIGURE 51.KONINKLIJKE DSM N.V..: NET SALES ($MILLION)
    FIGURE 52.CSPC PHARMACEUTICAL GROUP LIMITED.: NET SALES ($MILLION)
    FIGURE 53.MUBY CHEMICALS.: NET SALES ($MILLION)
    FIGURE 54.NORTHEAST PHARMACEUTICAL GROUP CO., LTD..: NET SALES ($MILLION)
    FIGURE 55.LUWEI PHARMACEUTICAL GROUP CO., LTD.: NET SALES ($MILLION)
    FIGURE 56.ACP CHEMICALS INC.: NET SALES ($MILLION)
    FIGURE 57.MERCK KGAA.: NET SALES ($MILLION)
    FIGURE 58.FOODCHEM INTERNATIONAL CORPORATION.: NET SALES ($MILLION)
    FIGURE 59.BLAGDEN SPECIALITY CHEMICALS LTD..: NET SALES ($MILLION)
    FIGURE 60.BACTOLAC PHARMACEUTICAL INC..: NET SALES ($MILLION)
    FIGURE 61.ALAND HEALTH HOLDING LTD.: NET SALES ($MILLION)
    FIGURE 62.FUJIFILM CORPORATION.: NET SALES ($MILLION)
    FIGURE 63.MEDISCA INC..: NET SALES ($MILLION)
    FIGURE 64.SUPERIOR SUPPLEMENT MANUFACTURING.: NET SALES ($MILLION)
    FIGURE 65.PHARMAVIT.: NET SALES ($MILLION)
    FIGURE 66.RECKON ORGANICS PRIVATE LTD..: NET SALES ($MILLION)
    FIGURE 67.CHEMCEED.: NET SALES ($MILLION)
    FIGURE 68.BOTANIC HEALTHCARE.: NET SALES ($MILLION)
    FIGURE 69. VEGA GROUP COMPANY LIMITED.: NET SALES ($MILLION)
    FIGURE 70.GLANBIA PLC.: NET SALES ($MILLION)

Purchase Full Report of
Ascorbic Acid Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue